Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(33%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
8
67%
Ph early_phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting4
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
4
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

completed650%
recruiting433%
unknown18%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
12